i+solutions | LinkedIn (original) (raw)

``

Transport, logistiek, supplychain en opslag

Our mission is to save and improve lives by creating well-functioning health supply chains.

• Alle 120 medewerkers weergeven

Over ons

i+solutions’ vision is a world where all medical unmet needs are addressed with innovative solutions. Our mission is to save and improve lives by creating well-functioning health supply chains, ensuring all have access to affordable quality medicines and health care when needed. i+solutions is the leading procurement service agent (PSA) for HIV, TB, and malaria treatments, PPE and oxygen plants under the Global Fund’s Pooled Procurement Mechanism and StopTB Partnership/UNOPS' GDF project. i+solutions also works as PSA for other global donors and local governments. i+solutions offers 4PL and market access services to pharmaceutical companies who seek help to introduce their products in complex markets. i+solutions drives an innovative agenda to improve global health supply chains and combines procurement, training, project management, quality assurance and technical expertise to make a difference from the first to the last mile, closing the gap between patient and medicine. Impact by innovation. i+solutions is a foundation, based in Woerden, The Netherlands.

Branche

Transport, logistiek, supplychain en opslag

Bedrijfsgrootte

51 - 200 medewerkers

Hoofdkantoor

Woerden

Type

Non-profit

Opgericht

2005

Specialismen

Procurement, Essential Medicines, Capacity Building en Supply Chain Management

Locaties

Medewerkers van i+solutions

Updates

• i+solutions heeft dit gerepost
  
  Asset Management ||Operations Management || Air Separation Plant Operations
  2 w Bewerkt
  As part of efforts to ensure that medical grade oxygen is available locally in hospitals in LMICs, the Iplussolutions team was in Kankan Guinea last week to commission 1 of the 3 PSA duplex oxygen plants donated to the country by the Global Fund as part of the C19RM project. #everybreathcounts ##medicaloxygen #Guinea #oxygenplants #afrimed i+solutions
  
• 📢 100 oxygen plant sites in production! One hundred sites in 25 countries have started the preparation and construction to install a skid mounted or containerized O2 plant to produce #oxygen. i+solutions works as Procurement Agent for The Global Fund to not only deliver O2 plants to hospitals, but also to provide the structures and technically prepare the sites at hospital premises. Since 2021, we work with suppliers, engineers, logistic service providers, governments and our counterparts at The Global Fund, to #increase #access #to #medical #oxygen in low- and middle income countries. And now 100 sites are being constructed! 👏 Compliments to the team and all parties involved for reaching this siginifcant milestone!
  
• 
  13.798 volgers
  2 w Bewerkt
  The World Health Organization (WHO) published its Global Tuberculosis Report 2024 this week. Much has been achieved, an estimated 79 million lives were saved since 2020, but TB is far from over. 10.8 million people fell ill from the disease and 1.25 million died in 2023 alone. Increased effort and more funds are needed for prevention, diagnosis, treatment and care, so we may reach the SDG targets and end TB. The gaps are still very wide... Six vaccines are currently in Phase III trails, which gives us hope that those targets can still be reached by 2030. See the insightful WHO infographics below. Thanks KNCV TB Plus for sharing. As procurement agent for UNOPS/Stop TB Partnership, our team works hard every day to get TB medicines to patients. We are glad and proud to be able to contribute to the fight against TB. #EndTB #YesWeCanEndTB #TogetherWeCanEndTB
  📢 Yesterday, World Health Organization (WHO) published their Global Tuberculosis Report 2024 underscoring key advancements and challenges in the fight against #tuberculosis (TB). 🚨 It's 2024 and #TB continues to be the world's deadliest infectious disease! 🚨 This report is more than a summary; it’s a roadmap 🛣 for the urgent measures needed to counteract TB’s deadly toll. “Ending TB will require accelerated action in areas such as vaccine development, TB preventive treatment coverage, access to point-of-care-diagnostics, and funding,” says KNCV’s Executive Director Dr. Gidado Mustapha. 🙌 From KNCV TB Plus, we thank all frontline healthcare workers, partners, and donors for the invaluable progress made in TB prevention and care as reported by #WHO. 🤝 Together, let’s ensure that the fight against TB gains the momentum it critically needs, because lives depend on it. 🔗 Read more: https://lnkd.in/eE-QPHsD and check out the infographics prepared by WHO below 👇 #EndTB #TogetherWeCanEndTB #WHOReport #GlobalTBReport2024
  
• 
  13.798 volgers
  4 w Bewerkt
  Procuring oxygen plants and realizing site preparation at local health facilities is an important part of our activities on behalf of The Global Fund. We are grateful to work with partners like Sinopharm Fortune International Trading Corp. to get the job done! Congratulations to all on a successful commissioning! Together, we create impact by increasing access to oxygen and saving lives
  👏👏We are thrilled to announce the successful delivery of the PSA oxygen plant at Lumumba Referral Hospital in Zanzibar. The inauguration ceremony, attended by the Vice President, represents a major step forward in enhancing healthcare infrastructure. This project, with Sinopharm Fortune as a supplier to i+solutions, ensures a reliable oxygen supply, aiming to improve medical care and support the local community. We extend our gratitude to Kingbell International T&D Co. Ltd and all partners involved. Together, we are committed to advancing healthcare access and elevating global health standards.#PSA #ZanzibarHealth #OxygenSolutions #HealthcareAccess #GlobalHealthcare #EveryBreathCounts
  • +1
    
• i+solutions heeft dit gerepost
  Over the last two decades, working hand in hand with communities, governments, the private sector, civil society, and our technical partners, The Global Fund partnership has saved 65 MILLION lives and cut the combined death rate from AIDS, tuberculosis and malaria by 61%. Together, we are delivering on our promise to save lives and strengthen health systems. Learn more in the Global Fund 2024 Results Report: https://lnkd.in/dZKw5mKt
  
• Prevention is key to end HIV As announced at the #AIDS conference in July, the The Global Fund is launching the #PrEP #Ring Early Market Access Vehicle (EMAV). Up to US$2 million is available to purchase #dapivirine vaginal rings in countries implementing Global Fund #HIV grants. To learn more about the importance of diverse HIV prevention options, to get background information on the ring and understand how countries can benefit from EMAV, the Global Fund is organizing a #webinar on October 30th. Please find all details and a link to register below! Sharing is appreciated!
  
  Global Health Specialist
  1 mnd
  I am proud to invite you to the launch of an initiative that I have been passionately working on for the past few months, aimed at improving access to the dapivirine vaginal ring for women and girls who need it the most. In collaboration with CIFF, the Global Fund is launching the PrEP Ring Early Market Access Vehicle (EMAV), which was announced at the AIDS conference this July. This initiative will provide up to US$2 million to purchase dapivirine vaginal rings in countries implementing Global Fund HIV grants. Join us for an insightful session where we will discuss: - The importance of diverse HIV prevention options - Background on the dapivirine vaginal ring and future products - An overview of the EMAV, including how to benefit from it - Resources to support countries in developing their requests and introducing the ring Registration link: https://lnkd.in/eXaqzb_bDate: 30 October, 2024 Time: 9am East Coast, USA, 2pm Geneva, 3pm Johannesburg, 4pm Nairobi, 8pm Bangkok 📢 Please share this invitation with stakeholders who can benefit from this initiative.
  
• At i+solutions, we fully support The Global Fund’s efforts to make #oxygen available to all who need it and especially in low- and middle-income countries. Read all about the Global Oxygen Strategic Framework and Investment Case that The Global Fund launched during the World Health Summit in Berlin.
  Each year, hypoxaemia (low blood oxygen) directly contributes to the deaths of approximately 9 million people in low- and middle-income countries, including 1.6 million children under five. "We must act decisively to strengthen health systems & ensure oxygen is available to all who need it” Peter Sands, Executive Director of The Global Fund. Alongside #WHS2024, the Global Oxygen Alliance has launched its Global Oxygen Strategic Framework & Investment Case to transform access to this lifesaving medicine. Learn more: https://lnkd.in/e-9gfxSK
  
• 
  13.798 volgers
  1 mnd Bewerkt
  Impact of pharmaceutical access programs in low- and middle-income countries A few weeks ago, i+solutions’ Martin Mugisha had an interesting conversation with Dennis Choguya, Sales and Marketing Manager of Varichem Pharmaceuticals (Pvt). LTD from Zimbabwe, about the impact of the Sanofi insulin access program in Zimbabwe. The price went down by almost 50% for pharmacies and availability went up. They also talked more broadly about the challenges the local pharmaceutical market faces. We want to thank Dennis for the open conversation and for sharing his insights. Read the full article on our website https://lnkd.in/etjnYp3C🌍 World Health Summit, Berlin i+solutions’ COO Wesley Kreft is part of a panel discussion organized by Sanofi at the upcoming World Health Summit in Berlin about the power of partnerships to improve access to chronic care in low and middle income countries. 👉 Location: Lounge Cairo at JW Marriott hotel, Berlin 👉 Date & time: Monday October 14, 6-7.30 pm#accesstomedicines #leavonoonebehind #uhcPhotos courtesy of Varichem Pharmaceuticals
  
• Tomorrow, we celebrate World Oxygen Day 2024! The importance of #medical #oxygen for patients and lack thereof in many countries became painfully clear during the Covid-19 outbreak. In 2020, at the height of the pandemic, The Global Fund (TGF) initiated the Covid-19 Response Mechanism (C19RM) to strengthen implementing countries’ health and community systems, prioritising medical oxygen, respiratory care and therapeutics. Through C19RM, countries invest TGF grant funds to bolster health infrastructures by providing medical oxygen and associated clinical and non-clinical products. Medical oxygen is generally provided by pressure swing adsorption (PSA) plants, big industrial machines that require considerable infrastructural preparation. Mid 2021, i+solutions, procurement service agent for TGFs Pooled Procurement Mechanism (PPM), was awarded the contract for the procurement of these oxygen PSA plants. Since the start of the project, almost 200 plants for over 30 countries were procured with TGF funds and managed via the PPM. Delivering the containerized or skid-mounted (PSA) plants was hampered due to sites at receiving health facilities not being technically prepared. Hospital administrations did not know how to handle this, as existing buildings had to be adjusted or new buildings constructed, which required a lot of engineering. To improve the installation of the (PSA) plants, TGF asked i+solutions manage site preparation, so an oxygen team complete with architects, engineers and project managers was formed. Many challenges had to be overcome to manage all the stakeholders at different levels, to define the exact works to be performed and to include the specific local conditions at each site. The result has become very visible this past year. Currently, construction works are ongoing at 136 hospitals and the first 27 Plants have been commissioned. In most cases, there was no infrastructure available, and buildings needed to be designed and constructed from scratch, foundations had to be laid, medical gas piping systems and generators installed. At some sites, because of a lack of space, the plant needed to be delivered on top of an existing building, so engineers had to be inventive. Please find below a set of pictures showing what the site construction journey from beginning to end looks like. We are very proud of the work our oxygen team is doing. We want to thank our counterparts at The Global Fund, our suppliers Sinopharm Fortune International Trading Corp., Atlas Copco, AirSep Corporation , Novair , Ultra Controlo, Afrimed, MILS, Sumer, our logistic service providers A.P. Moller - Maersk, Logenix International and Bolloré Logistics and all staff at the in-country Ministries of Health, for their ongoing collaboration and help to achieve these results and expand access to oxygen for patients in low-and middle income countries.#WorldOxygenDay #EveryBreathCounts
  

Word nu lid en bekijk wat u mist

Nu lid worden

Vergelijkbare pagina’s

• IDA Foundation Geneesmiddelenproductie
• IMRES B.V. - Providing global access to quality medical care Geneesmiddelenproductie Lelystad, Flevoland
• The Medical Export Group BV Groothandel Vuren, Gelderland
• XS2Meds Transport, logistiek, supplychain en opslag Woerden, Utrecht
• The Global Fund Non-profitorganisaties Grand-Saconnex, Geneva
• The Partnership for Supply Chain Management Transport, logistiek, supplychain en opslag Arlington, Virginia
• Rituals Productie persoonlijke verzorgingsproducten Amsterdam, Noord-Holland
• Access to Medicine Foundation Non-profitorganisaties Amsterdam, Noord-Holland
• Missionpharma Geneesmiddelenproductie
• Afrimed Productie medische apparatuur

Door vacatures bladeren